ClinicalTrials.Veeva

Menu

The Effect of Sildenafil on Sleep-Disordered Breathing in Obese Patients With Sexual Dysfunction

S

Shamir Medical Center (Assaf-Harofeh)

Status

Unknown

Conditions

Sildenafil
Sexual Dysfunction
Obesity
Sleep Apnea

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Sildenafil has been shown to aggravate sleep-disordered breathing in patients with severe obstructive sleep apnea. The aim of the present study is to examine the frequency of sleep-disordered breathing in obese patients who are candidates for treatment with sildenafil for sexual dysfunction. In addition we wish to assess the effect of sildenafil on sleep-disordered breathing.

Enrollment

50 estimated patients

Sex

Male

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age - 40-65 years
  • BMI equal to or over 30

Exclusion criteria

  • A known cardiorespiratory, liver or kidney disease
  • Treatment with nitrates or alfa blockers
  • Performed polysomnography in the past

Trial design

50 participants in 2 patient groups

Sildenafil
Description:
Treated with 50 mg of Sildenafil at night
Placebo
Description:
Treated with placebo at night

Trial contacts and locations

1

Loading...

Central trial contact

Isaac Shpiree, MD; Arnon Elizur, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems